A disintegrin and metallopeptidase domain (ADAM) 12, ADAM 17 mRNA and ADAM10 protein hold potential as biomarkers for detection of early gastric cancer.

MLA

Oh, Sooyeon, et al. “A Disintegrin and Metallopeptidase Domain (ADAM) 12, ADAM 17 MRNA and ADAM10 Protein Hold Potential as Biomarkers for Detection of Early Gastric Cancer.” Scientific Reports, vol. 14, no. 1, Jan. 2025, pp. 1–12. EBSCOhost, https://doi.org/10.1038/s41598-024-84237-y.

APA

Oh, S., Lee, S.-S., Jin, H., Choi, S.-H., Cha, C.-K., Lee, J., Kwack, K., Kim, S. G., & Choi, S.-W. (2025). A disintegrin and metallopeptidase domain (ADAM) 12, ADAM 17 mRNA and ADAM10 protein hold potential as biomarkers for detection of early gastric cancer. Scientific Reports, 14(1), 1–12. https://doi.org/10.1038/s41598-024-84237-y

Chicago

Oh, Sooyeon, Sang-Soo Lee, Hoeyoung Jin, Seo-Hyeon Choi, Choong-Keun Cha, Jooho Lee, KyuBum Kwack, Sang Gyun Kim, and Sang-Woon Choi. 2025. “A Disintegrin and Metallopeptidase Domain (ADAM) 12, ADAM 17 MRNA and ADAM10 Protein Hold Potential as Biomarkers for Detection of Early Gastric Cancer.” Scientific Reports 14 (1): 1–12. doi:10.1038/s41598-024-84237-y.